HER2 targeting agent

NZ834885APending Publication Date: 2026-07-31ONO PHARMA CO LTD +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
NZ834885
Authority / Receiving Office
NZ · NZ
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-07-02
Filing Date
2021-11-29
Publication Date
2026-07-31

Smart Images

  • Figure 00000105_0000
    Figure 00000105_0000
  • Figure 00000106_0000
    Figure 00000106_0000
  • Figure 00000107_0000
    Figure 00000107_0000
Patent Text Reader

Abstract

The present invention provides an antibody or antigen-binding fragment thereof that binds to HER2 expressed on a cancer cell or a fragment of the HER2, a HER2-targeting agent containing any of these, and a pharmaceutical composition containing the HER2-targeting agent.
Need to check novelty before this filing date? Find Prior Art